The invention describes an improved process for the synthesis and purification of paliperidone.
Paliperidone, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, is a 5-HT antagonist belonging to the chemical class of benzisoxazole derivatives and a racemic mixture has the following structural formula (I):
Paliperidone is a primary active metabolite of risperidone, Marketed under the name Invega® paliperidone is a psychotropic agent approved for the treatment of schizophrenia.
A process for the synthesis of paliperidone, is described e.g. in
The process is performed in the presence of an organic base and involves isolations using column chromatography and re-crystallizations in suitable solvents, The most persistant impurity to be removed from the active ingredient is 3-[2-[4-(6-fluoro-1,2-benzoisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-7,8-dihydro-4H-pyrido[1,2-a]pyrimidin-4,9(6H)-dione (IV) of formula
A process for the synthesis of CMHTP is described in
There is a need in the art for a new process for preparing paliperidone and its intermediates.
The present application relates to an improved process for preparing paliperidone of formula (I) by combining 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrrido[1,2-a]-pyrimidin-4-one (CMHTP) or a salt thereof and 6-fluoro-3-piperidino-1,2-benzisoxazol (FBIP) or a salt thereof in an organic solvent and in the presence of water, wherein the pH value of the reaction medium is between 6 and 14, preferably between 8 and 11, and wherein active charcoal is used in the crystallization step(s), the active charcoal having a neutral or alkaline pH value when dispersed in water and a content of individual metal cations (e.g. Zn2+, Fe2+ cations) less than 200 ppm, leading to a product with a much reduced content of the impurities (IV and others) and wherein tedious purification steps may be omitted in comparison with prior processes for the preparation of paliperidone.
The present application relates to an improved process for preparing paliperidone of formula (I) by combining 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrrido[1,2-a]-pyrimidin-4-one (CMHTP) or a salt thereof and 6-fluoro-3-piperidino-1,2-benzisoxazol (FBIP) or a salt thereof in an organic solvent and in the presence of water, wherein the pH value of the reaction medium is between 6 and 14, preferably between 8 and 11, and wherein active charcoal is used in the crystallization step(s), the active charcoal having a neutral pH value when dispersed in water and a content of individual metal cations (e.g. 2n2+, Fe2+ cations) less than 200 ppm, leading to a product with a much reduced content of the impurity (IV and other impurities) and wherein tedious purification steps may be omitted in comparison with prior processes for the preparation of paliperidone.
Preferably, the reaction occurs in mixtures of an organic solvent, such as Cl-8 alkyl alcohols, acetonitrile, C3-6 amides, C3-6 ketones, C5-12 aromatic hydrocarbons, C2-6 alkyl acetates and C2 -8 ethers, with water.
Preferred Cl-4 alkyl alcohols are methanol, ethanol, n-propanol, isopropanol (IPA), n-butanol, isobutanol and 2-butanol. Preferred C3-6 amides are dimethylacetamide and dimethylformamide (DMF). Preferred C3-6 ketones are acetone, methyl ethyl ketone (MEK) and methyl iso-butyl ketone (MIBK). Preferred C2-6 alkyl acetates are ethyl acetate and isobutyl acetate. Preferred C2-8 ethers are tetrahydrofurane (THF), diethoxymethane (DEM), isobutyl methyl ether, dibutyl ether and polyethylene glycol (PGME).
Most preferably, the reaction is carried out in a mixture of methanol and water. The water may either be added to the reaction mixture directly, or indirectly, comprised in the base, e.g. diisopropylamine or diisopropylethylamine. In case it is added indirectly, the water content of the base, e.g. diisopropylamine or diisopropylethylamine, has to be determined prior to the reaction, and the missing fraction added directly to the reaction mixture.
In the process of the present invention for preparing paliperidone, the added water fraction in the solvent mixture used can be from 0.5 % (V/V) to 10% (V/V). Preferably the water fraction in the solvent mixture is from 0.5 to 5.0, most preferably from 0.5 to 2.0%.
In the process of the present invention for preparing paliperidone, the inorganic or organic base used can be in a ratio of about 1 to about 3 moles of the base per mole of CMHTP such as about 2.5 moles of the base per mole of CMHTP. The amount of the base used, preferably, is in a molar ratio of about 2, i.e., about 2 moles of the base per mole of CMHTP, such as about 1.8 moles of the base per mole of CMHTP.
Preferably, the reaction occurs under nitrogen (oxygen is degassed from the reaction mixture) and protected from light, in order to avoid the color formation, attributed to some of the impurities.
Typically, the obtained reaction mixture is heated, preferably to a temperature of about 50 °C to about reflux, most preferably to a temperature of about 65 °C to about 70 °C. In a preferred embodiment, the reaction temperature is achieved by slow heating. Preferably such a temperature gradient is applied that a reaction mixture of about 200 to 300 g is heated to the reaction temperature in more than 60 minutes, preferably more than 75 minutes.
The heated mixture is preferably maintained for at least about 5 hours, for the reaction to take place. Preferably, the reaction mixture is maintained for at least about 15 hours, and most preferably, for at least about 30 hours.
Subsequently, the reaction mixture is cooled or the product may be hot filtered. If cooling is applied, it is gradual, to about room temperature, preferably to a temperature of about 30 °C and between 30 and 90 minutes. As used herein, "room temperature" relates to a temperature of about 20 °C to about 25 °C.
After the cooling step, solid paliperidone is formed, which is then recovered by methods known in the art, such as filtration or centrifugation. Preferably, the obtained paliperidone is first washed with an organic solvent, which is the organic solvent used in the reaction, such as methanol, acetonitrile, acetone, dichloromethane or IPA, optionally followed by drying. Preferably, the drying is performed at about 50 °C for about 3 - 6 h.
Both CMHTP and FBIP starting materials can be in the form of a base or acid addition salts. Most preferred salt is a hydrochloride salt. CMHTP may be obtained by any method known in the art, such as the ones described in
CMHTP may contain less than 0.5%, preferably less than 0.2% and more preferably less than 0.05% of impurity of the following formula (V)
The crude paliperidone according to the present invention, either still wet with a water/methanol content of 3 % w/w to below 1 % w/w directly from the filtration/centrifugation step, or first dried until the loss on drying is bellow 1 % w/w, is macerated in water. The ratio between the mass of the wet or dry crude paliperidone and the volume of water used is between 0.2 g/mL and 0.05 g/mL. The maceration in water is carried out at a temperature between 60 and 99 °C, preferably between 85 and 95 °C. The paliperidone may further be purified, for example, by re-crystalliz,ation such as recrystallization from isopropanol, in the presence of an active charcoal having a neutral pH value when dispersed in water and a content of metal cations (each) less than 200 ppm, as determined by atomic absorption spectrometry.
Optionally, the particle size may be optimized to the average diameter of 20 to 60 micrometers, preferably to the average diameter from 20 - 30 micrometers prior to its isolation with the use of an ultraturrax. In this way, paliperidone with a narrow distribution function is prepared, and the process is easily controlled and repeatable without the need for a second milling process. As the ultraturrax any commercially available product may be used, such as Ultra-Turrax®.
The obtained crystalline form of paliperidone is characterized by powder X-ray diffraction (PXRD) pattern having peaks at about: 8,3, 10.4, 14.7, 15.1, 16.3, 18.8, 20.2, 20.8, 22.2, 24.8, 25.2 and 28.1 ± 0.2 degrees two theta.
The XRD diffractogram was recorded on a Phillips PW3040/60 X'Pert PRO diffractometer using CuKα radiation (1,541874 A).
The content of the impurity (IV) in the product obtained is below 0.15 % as determined with the following HPLC analytical method:
Accurately weigh about 5 mg of sample into 10 mL volumetric flask, dissolve and dilute to volume with diluent.
Use area per cent method. Do not integrate solvent peaks.
The present invention is illustrated by the following Examples without being limited thereto.
20.00 g of 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazol hydrochloride; 19.82 g of 3-(2-chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]pyrimidin-4-one; from 23.62 g to 27.54 g (33 mL to 38,4 mL) of dry diisopropylamine; 0.70 mL of water and 100 mL to 140 mL of methanol were charged to a 500 mL three-necked flask at room temperature, pH of suspension is 10,1. The reaction was carried out in inert atmosphere (N2) and protected from light. The suspension was heated to 65 °C to 67 °C in 90 minutes until a clear solution was obtained, After one hour the reaction product began to precipitate from the reaction mixture. The reaction mixture was left at 65 - 67 °C for 30 hours, cooled to 30 °C in 60 minutes, stirred for 30 minutes at 30 °C and filtered. The product was washed with 40 mL of methanol. 27,5 g of paliperidone with a water content of 0,5 % were isolated, Purity was 98.6 area %, level of impurity (IV) was 0.12 area %.
10.1 g of the wet crude paliperidone obtained as described in Example 1 were suspended in 100 mL of demineralized water under inert atmosphere (N2) and heated to 97 - 99°C. The suspension was stirred for 15 minutes and hot filtered. The product was washed with 20 mL of water and dried until LOD (Loss on Drying) was below 1% (w/w). 8.84 g of dry paliperidone were obtained, Purity was 98.8 area %, level of impurity (IV) was 0.12 area %.
9.20 g of the wet macerated paliperidone of Example 2 (containing 9.08 g of the dry product) were charged to a 1000 mL three-necked flask under inert atmosphere (N2) and dissolved in 644 mL 2-propanol. 0.46 g of active charcoal (metal cations less than 200 ppm) was added. The mixture was heated to reflux (82 °C) and stirred for 15 minutes. The suspension was hot filtered over randalite and the filtrate was cooled to room temperature. Crystallization of the product was provoked by seeding (cca 2% (w/w). The product started to precipitate between 56 °C to 50 °C. After the filtration, the product was washed with 13.8 mL of 2-propanol. 8.12 g of the wet product were obtained. The product may be dried in a vacuum drier at 50 °C or directly used in a second crystallization. Preferably, the wet product is directly used. Purity was 99.5 area %, level of impurity (IV) was 0.12 area %.
9.20 g of the wet macerated paliperidone of Example 2 (containing 9.08 g of the dry product) were charged to a 1000 mL three-necked flask under inert atmosphere (N2) and dissolved in 644 mL 2-propanol, 0.46 g of active charcoal (metal cations less than 200 ppm) was added. The mixture was heated to reflux (82 °C) and stirred for 15 minutes, The suspension was hot filtered over randalite and the filtrate was cooled to room temperature. Crystallization of the product was provoked with the use of the ultraturrax. The product started to precipitate between 56 °C to 50 °C. After the filtration, the product was washed with 13.8 mL of 2-propanol. 8.12 g of the wet product were obtained. The product may be dried in a vacuum drier at 50 °C or directly used in a second crystallization, Preferably, the wet product is directly used. Purity was 99.5 area %, level of impurity (IV) was 0.12 area %.
The product obtained according to Examples 3A and 3B can be further recrystallized in order to improve the purity of the product.
1.04 kg of 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazol hydrochloride, 1.03 kg of 3-(2-chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]pyrimidin-4-one; 1.72 L of dry diisopropylamine, 0.04 L of water and 5.2 L of methanol were charged to a reactor at room temperature. The reaction was carried out in inert atmosphere (N2) and protected from light. The suspension was heated to 65 °C to 67 °C in 120 minutes until a clear solution was obtained. The reaction mixture was left at 65 - 67 °C for 30 hours, cooled to 30 °C in 125 minutes, stirred for 30 minutes at 30 °C and filtered. The product was washed with 2 L of methanol. 1.69 kg of wet paliperidone (1.53 kg of dry crude paliperidone) with a solvent content of 9.6 % were isolated. Purity was 98.2 area %, level of impurity (IV) was 0.12 area %.
1.69 kg of the wet crude paliperidone obtained as described in Example 4 were suspended in 15.3 L of demineralized water under inert atmosphere (N2) and heated to 97 - 99 °C. The suspension was stirred for 15 minutes and hot filtered. The product was washed with 1.2 L of water and dried until LOD (Loss on Drying) was below 1% (w/w). 1.4 kg of wet paliperidone were obtained. Purity is 98,5 area %, level of impurity (IV) was 0.12 area %.
1.4 kg of the dry macerated paliperidone of Example 5 were charged to a reactor under inert atmosphere (N2) and dissolved in 98 L 2-propanol. 0.06 g of active charcoal (metal cations less than 200 ppm) was added. The mixture was heated to reflux (82 °C) and stirred for 15 minutes. The suspension was hot filtered over randalite and the filtrate was cooled to room temperature. The product started to precipitate between 56 °C to 50 °C. After the filtration, the product was washed with 2 L of 2-propanol. 1.23 kg of the wet product were obtained. The product was dried in a vacuum drier at 50 °C. Purity was 99.5 area %, level of impurity (IV) was 0.12 area % and mass of dry product was 1.13 kg.
1.04 kg of 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazol hydrochloride, 1.03 kg of 3-(2. chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]pyrimidin-4-one; 1.72 L of dry diisopropylethylamine, 0.04 L of water and 5.2 L of methanol were charged to a reactor at room temperature. The reaction was carried out in inert atmosphere (N2) and protected from light. The suspension was heated to 65 °C to 67 °C in 140 minutes until a clear solution was obtained. The reaction mixture was left at 65 - 67 °C for 30 hours, cooled to 30 °C in 50 minutes, stirred for 30 minutes at 30 °C and filtered. The product was washed with 2.5 L of methanol. 1.65 kg of wet paliperidone (1.50 kg of dry crude paliperidone) with a solvent content of 9.3 % were isolated. Purity was 98.2 area %, level of impurity (IV) was 0.06 area %.
1.65 kg of the wet crude paliperidone obtained as described in Example 7 were suspended in 15 L of demineralized water under inert atmosphere (N2) and heated to 97 - 99 °C. The suspension was stirred for 15 minutes and hot filtered, The product was washed with 1.2 L of water and dried until LOD (Loss on Drying) was below 1% (w/w). 1.5 kg of wet paliperidone were obtained. Purity is 98.6 area %, level of impurity (IV) was 0.06 area %.
1.4 kg of the dry macerated paliperidone of Example 8 were charged to a reactor under inert atmosphere (N2) and dissolved in 98 L 2-propanol. 0.06 g of active charcoal (metal cations less than 200 ppm) was added. The mixture was heated to reflux (82 °C) and stirred for 15 minutes. The suspension was hot filtered over randalite and the filtrate was cooled to room temperature. The product started to precipitate between 56 °C to 50 °C. After the filtration, the product was washed with 2 L of 2-propanol. 1.11 kg of the wet product were obtained. The product was dried in a vacuum drier at 50 °C. Purity was 99.4 area %, level of impurity (IV) was 0.06 area % and mass of dry product was 1.11kg.
2 g of macerated paliperidone from Example 5 were suspended in 140 mL of 2-propanol and 0.1 g of active charcoal (Zn more than 200 ppm) was added. The mixture was heated to reflux (82 °C) and stirred for 15 minutes. The suspension was hot filtered over randalite and the filtrate was cooled to room temperature. The product started to precipitate between 56 °C to 50 °C. After the filtration, the product was washed with 4 mL of 2-propanol, Purity of wet product was 93.1 area %, level of impurity (IV) was 1.57 area %.
1 g of paliperidone (level of impurity (IV) was 0.75 area %), 30 mL of water and 1.57 g ZnCl3 (anhydrous) were charged in 50 mL three-necked flask, heated to 60 C for 30 hours and analyzed. Level of impurity (IV) was 30.2 area %
Same as in example 11, but without the addition of ZnCl2. Level of impurity (IV) was 0.93 %.
Same as in example 12, but water had pH 10. Level of impurity (IV) was 0.92 %.
Same as in example 11, but water had pH 10. Level of impurity (IV) was 7.5%.
Same as in example 12, but water had pH 3. Level of impurity (IV) was 59.9 %.
1 g paliperidone (level of impurity (IV) was < 0,1 area %), 10 mL metanol, 0,3 mL water and in so much HCl(aq) or diisopropylamin, that the pH of suspension is according to the values written in the table were charged to the flask and heated to the reflux for 24 hours. Samples of suspensions were taken and analysed. Results are presented in the table below.
1 g of paliperidone (level of impurity (IV) was 0.75 area %), 30 mL of water and 1.86 g FeCl2 (anhydrous) were charged in 50 mL three-necked flask, heated to 60 °C for 42 hours and analyzed. Levels of impurities (RRT 0.81 and RRT 1.29) were 60 and 14 area %